Hemminki A, Tomlinson I, Markie D, Järvinen H, Sistonen P, Björkqvist A M, Knuutila S, Salovaara R, Bodmer W, Shibata D, de la Chapelle A, Aaltonen L A
Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.
Nat Genet. 1997 Jan;15(1):87-90. doi: 10.1038/ng0197-87.
Many human cancer susceptibility genes have been successfully mapped by genetic linkage studies. One that has so far eluded researchers is that for Peutz-Jeghers (P-J) syndrome, a condition characterized by intestinal hamartomatous polyposis and melanin spots of the lips, buccal mucosa and digits. A dramatically elevated risk of malignancy has also been documented. Gastrointestinal tumours as well as cancers of the breast, ovary, testis and uterine cervix appear to be overrepresented in families with this syndrome. The nature of hamartomatous polyps is equivicol. Hamartomas are usually considered histologically benign, but in the case of Peutz-Jeghers patients, there are reports of adenomatous and malignant changes in the polyps, and the possibility of a hamartoma-carcinoma sequence has been discussed. A search for a putative tumour suppressor locus was made using comparative genomic hybridization (CGH) of Peutz-Jeghers polyps, combined with loss of heterozygosity (LOH) study. Genetic linkage analysis in 12 families using markers from a deletion site demonstrated the presence of a high-penetrance locus in distal 19p with a multipoint lod score of 7.00 at marker D19S886 without evidence of genetic heterogeneity. The study demonstrates the power of CGH combined with LOH analysis in identifying putative tumour suppressor loci, and provides molecular evidence of malignant potential in hamartomas.
许多人类癌症易感基因已通过遗传连锁研究成功定位。迄今为止,研究人员尚未找到的一个基因是与佩-吉(P-J)综合征相关的基因,该综合征的特征是肠道错构瘤性息肉病以及嘴唇、颊黏膜和手指上的黑色素斑。恶性肿瘤风险显著升高也有文献记载。在患有这种综合征的家族中,胃肠道肿瘤以及乳腺癌、卵巢癌、睾丸癌和子宫颈癌的发病率似乎过高。错构瘤性息肉的性质尚不清楚。错构瘤通常在组织学上被认为是良性的,但在佩-吉综合征患者中,有报道称息肉出现腺瘤性和恶性变化,并且已经讨论了错构瘤-癌序列的可能性。利用佩-吉息肉的比较基因组杂交(CGH)结合杂合性缺失(LOH)研究,寻找一个假定的肿瘤抑制基因座。使用来自一个缺失位点的标记对12个家族进行遗传连锁分析,结果表明在19号染色体短臂远端存在一个高外显率基因座,在标记D19S886处的多点对数得分是7.00,且没有遗传异质性的证据。这项研究证明了CGH与LOH分析相结合在识别假定肿瘤抑制基因座方面的作用,并提供了错构瘤具有恶性潜能的分子证据。